InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: learning curve post# 73766

Thursday, 03/19/2015 11:57:26 PM

Thursday, March 19, 2015 11:57:26 PM

Post# of 80868
Brad's salary for last year was for the most part pre-paid...it was a stock grant to pay him over the next 5 years.

Equity based compensation to Brad won't happen in 2015 and in 2016....and I have a feeling that he won't receive much cash this year either.

Musclepharm got $100 million to pay all non manufacturing expenses with and make a profit with....it's not a terribly large amount of money when you spend 30% on endorsements and advertising alone.

Naturally, the more Musclepharm sells for...the easier to pay the bills and to pay large cash bonuses to executives. As long as Musclepharm only got $100 million post manufacturing costs, it's still limited what it can spend money on.

Right now, many executives hold large stock grants, so that should be something to motivate them to perform at realistic salaries.